The outcomes of post-grant appeals from the PTAB to the Federal Circuit in October, November, and December were generally in line with long-term trends favoring appellees. In October, the Federal Circuit affirmed the PTAB on every issue in 7 cases (87.5%).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Audrey J. Parker
Federal Circuit PTAB Appeal Statistics For July, August, And September 2024
In post-grant appeals from the PTAB to the Federal Circuit in July, August, and September, the outcomes were generally in line with long-term trends in favoring appellees. In July, the Federal Circuit affirmed the PTAB on every issue in 12 cases (75%), including its precedential opinion in Sanho Corp. v. Kaijet Technology International Ltd. (No. 23-1336). The court also reversed or vacated every issue in 2 appeals (12.5%).
Federal Circuit PTAB Appeal Statistics For June 2024
June was another favorable month for appellees at the Federal Circuit in post-grant proceeding appeals from the Patent Trial and Appeal Board (PTAB). The court affirmed the PTAB on every issue in 9 cases (81.82%) and reversed or vacated every issue in 1 appeal (9.09%). The court issued a mixed outcome, in which at least one issue was affirmed and at least one issue was not, in 1 case (9.09%). No appeals were dismissed on substantive (e.g., non-settlement) grounds.
Pre-Filing Private Sales Cannot Antedate Prior-Art References Under The § 102(b)(2)(B) "Public Disclosure" Exception
In Sanho Corp. v. Kaijet Technology International Ltd., Inc., No. 23-1336 (Fed. Cir. July 31, 2024), the Federal Circuit affirmed the Patent Trial and Appeal Board's decision that the inventor's pre-filing private sale of a product cannot be used to antedate a prior-art reference under the "public disclosure" exception in 35 U.S.C. § 102(b)(2)(B) (AIA) ("A disclosure made 1 year or less before the effective filing date of a claimed invention shall not be prior art to the claimed invention . . .
New Government, New Developments In Digital Law
In July 2024, the UK elected a new Labour government. With this new government comes new proposals for legislation, outlined in the King's Speech on 17 July 2024, which opened the first session of the new parliament since the general election. Below, we outline the key legislative plans in the digital sector. The UK data economy represents an estimated 6.9 per cent of the country's GDP.
Federal Circuit PTAB Appeal Statistics For April And May 2024
In post-grant appeals from the PTAB to the Federal Circuit in April and May, the outcomes skewed heavily in favor of appellees. In April, the Federal Circuit affirmed the PTAB on every issue in 11 cases (91.67%) and reversed or vacated every issue in 1 appeal (8.33%). The court did not issue any opinions with mixed outcomes, in which at least one issue was affirmed and at least one issue was not, and did not dismiss any appeals on substantive (e.g., non-settlement) grounds.
Federal Circuit PTAB Appeal Statistics For February And March 2024
In both February and March, the Federal Circuit affirmed a similar percentage of appeals from PTAB post-grant proceedings. The Federal Circuit in February affirmed the PTAB on every issue in 7 cases (70%) and reversed or vacated every issue in 2 appeals (20%), including in two precedential opinions: Google LLC v. EcoFactor, Inc. (No. 22-1750) and Weber, Inc. v. Provisur Technologies, Inc. (No. 22-1751).
Special Report: Trends In Federal Circuit PTAB Appeals Through 2023
In this special report, we review trends over time in PTAB post-grant appeals to the Federal Circuit. Through December 31, 2023, the Federal Circuit cumulatively decided 1,247 appeals from the PTAB in IPRs, CBMs, and PGRs. Yet the number of opinions in PTAB appeals has not remained constant over time; in 2015, the first year it heard appeals from AIA post-grant proceedings, the Federal Circuit issued only 47 opinions.
Federal Circuit PTAB Appeal Statistics For December 2023 And January 2024
In December, the Federal Circuit affirmed the PTAB on every issue in 9 (90%) cases on appeal from post-grant proceedings, including in one precedential opinion: ParkerVision, Inc. v. Vidal (Case No. 22-1548). The Federal Circuit dismissed 1 (10%) appeal and did not issue any opinions with mixed outcomes (in which at least one issue is affirmed) or any opinions in which every issue was vacated or reversed.
Federal Circuit PTAB Appeal Statistics For September And October 2023
In September, the Federal Circuit affirmed the PTAB on every issue in 8 (66.67%) cases on appeal from post-grant proceedings, including in two precedential opinions: Sisvel International S.A. v. Sierra Wireless, Inc. (Case No. 22-1387) and Elekta Limited v. Zap Surgical Systems, Inc. (Case No. 21-1985). The Federal Circuit issued a mixed outcome in 3 (25%) appeals, including its precedential decision in Netflix, Inc. v. DivX, LLC (Case No. 22-1138).
Federal Circuit PTAB Appeal Statistics For August 2023
In August, the Federal Circuit affirmed the PTAB on every issue in 9 (81.82%) cases on appeal from post-grant proceedings, including in four precedential opinions: Axonics, Inc. v. Medtronic, Inc. (Case No. 22-1532), Rembrandt Diagnostics, LP v. Alere, Inc. (No. 21-1796), Incept LLC v. Palette Life Sciences, Inc. (No. 21-2063), and Volvo Penta of the Americas, LLC v. Brunswick Corp. (No. 22-1765).
Federal Circuit PTAB Appeal Statistics for August 2023
In August, the Federal Circuit affirmed the PTAB on every issue in 9 (81.82%) cases on appeal from post-grant proceedings, including in four precedential opinions: Axonics, Inc. v. Medtronic, Inc. (Case No. 22-1532), Rembrandt Diagnostics, LP v. Alere, Inc. (No. 21-1796), Incept LLC v. Palette Life Sciences, Inc. (No. 21-2063), and Volvo Penta of the Americas, LLC v. Brunswick Corp. (No. 22-1765).
Federal Circuit PTAB Appeal Statistics For June And July 2023
In June, the Federal Circuit affirmed the PTAB on every issue in 16 (88.89%) cases on appeal from post-grant proceedings, including in five precedential opinions: Medtronic, Inc. v. Teleflex Innovations S.A.R.L. (three separate precedential opinions, Case Nos. 21-2356, -2357, and -2359), Yita LLC v. MacNeil IP LLC (No. 22-1373), and Parus Holdings, Inc. v. Google LLC (No. 22-1269).
Federal Circuit PTAB Appeal Statistics For May 2023
In May, the Federal Circuit affirmed the PTAB on every issue in 12 (80%) cases on appeal from post-grant proceedings, including in three precedential opinions: Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. (No. 21-1981), Bot M8 LLC v. Sony Interactive Entertainment LLC (No. 22-1291), and Medtronic, Inc. v. Teleflex Innovations S.A.R.L. (Nos. 21-2356, -2358, -2361, -2363, and -2365).
Federal Circuit PTAB Appeal Statistics For April 2023
In April, an unusually difficult month for appellants, the Federal Circuit affirmed the PTAB on every issue in 16 (94.12%) cases on appeal from post-grant proceedings, including in one precedential opinion: Arbutus Biopharma Corp. v. ModernaTX, Inc. (No. 20-1183). The Federal Circuit issued a mixed outcome in 1 (5.88%) appeal and did not issue any opinion in which it reversed or vacated every issue on appeal.
Federal Circuit PTAB Appeal Statistics for February 2023
[Editor’s Note: Given the near-total decline of CBM appeals since the sunset of the CBM program in September 2020, we will no longer list CBM appellate outcomes in our monthly statistics charts. We will continue to include historical CBM outcomes in our cumulative PTAB statistics.] In February, the Federal Circuit affirmed the PTAB on every issue in 9 (81.82%) cases on appeal from post-grant proceedings and reversed or vacated on every issue in 2 (18.18%) cases.
Federal Circuit PTAB Appeal Statistics for January 2023
In January, an unusually favorable month for appellees, the Federal Circuit affirmed the PTAB on every issue in post-grant proceeding appeals. Specifically, the Federal Circuit affirmed the PTAB in 8 (100%) cases and did not issue any mixed outcomes, reverse or vacate every issue on the merits, or dismiss any appeals on non-settlement grounds.
Federal Circuit PTAB Appeal Statistics for September 2022
In September, the Federal Circuit affirmed the PTAB on every issue in 3 (60%) cases on appeal from post-grant proceedings, and issued a mixed outcome in 2 (40%) cases, which occurs when at least one issue is affirmed and at least one issue is vacated or reversed in an opinion.
Federal Circuit PTAB Appeal Statistics for July and August 2022
In July, the Federal Circuit affirmed the PTAB on every issue in 7 (70%) cases on appeal from post-grant proceedings, reversed or vacated the PTAB on every issue in 1 (10%) case, and issued a mixed outcome in 2 (20%) cases, which occurs when at least one issue is affirmed and at least one issue is vacated or reversed in an opinion.
Federal Circuit PTAB Appeal Statistics Through June 30, 2022
In an unusually favorable month for appellees, the Federal Circuit in June affirmed the PTAB on every issue in 10 (90.91%) cases and issued a mixed outcome in 1 (9.09%) case in appeals from PTAB post-grant proceedings. A mixed outcome occurs where at least one issue is affirmed and at least one issue is reversed or vacated.
Federal Circuit PTAB Appeal Statistics Through April 30, 2022
Through April 30, 2022, the Federal Circuit decided 1,035 appeals from the PTAB in IPRs, CBMs, and PGRs. While the vast majority of these appeals came from IPRs, the number of PGR appeals has slowly increased over time, partially offsetting a near-total decline in the number of CBM appeals. In IPR appeals, the Federal Circuit has cumulatively affirmed the PTAB on every issue in 708 (72.76%) cases and reversed or vacated the PTAB on every issue in 129 (13.26%) cases.
Dying in Style
In 2016, after living with chronic, debilitating pain for two years, I was diagnosed with invasive ductal carcinoma—stage-4 breast cancer that had metastasized in most of my skeleton. It was the disease that would claim my life. For some reason, I remained calm when I received my terminal diagnosis. I felt from that very moment that it was senseless to panic over something I had no control over. I was relieved to finally know what was wrong with me.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Audrey J.
Contact Audrey J., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack